Literature DB >> 33270144

Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy.

Sai Man Cheung1, Ehab Husain2, Vasiliki Mallikourti3, Yazan Masannat4, Steven Heys4, Jiabao He3.   

Abstract

OBJECTIVES: Despite improved survival due to new treatments, the 10-year survival rate in patients with breast cancer is approximately 75%. Lymphovascular invasion (LVI), a prognostic marker independent from histological grade and stage, can only be fully determined at final histological examination. Lipid composition is deregulated in tumour via de novo lipogenesis, with alteration in lipogenic genes in LVI. We hypothesise alteration in lipid composition derived from novel non-invasive spectroscopy method is associated with LVI positivity.
METHODS: Thirty female patients (age 39-78) with invasive ductal carcinoma were enrolled, with 13 LVI negative and 17 LVI positive. Saturated, monounsaturated, polyunsaturated fatty acids and triglycerides (SFA, MUFA, PUFA and TRG) were quantified from ex vivo breast tumours freshly excised from patients on a 3 T clinical MRI scanner, and proliferative activity marker Ki-67 and serotonin derived histologically.
RESULTS: There were significantly lower MUFA (p = 0.0189) in LVI positive (median: 0.37, interquartile range (IQR): 0.25-0.64) than negative (0.63, 0.49-0.96). There were significantly lower TRG (p = 0.0226) in LVI positive (1.32, 0.95-2.43) than negative (2.5, 1.92-4.15). There was no significant difference in SFA (p = 0.6009) or PUFA (p = 0.1641). There was no significant correlation between lipid composition against Ki-67 or serotonin, apart from a borderline negative correlation between PUFA and serotonin (r = - 0.3616, p = 0.0496).
CONCLUSION: Lipid composition might provide a biomarker to study lymphovascular invasion in breast cancer. KEY POINTS: • Monounsaturated fatty acids in lymphovascular invasion (LVI) positive invasive breast carcinoma were significantly lower than that in LVI negative. • Triglycerides in LVI positive invasive breast carcinoma were significantly lower than that in LVI negative. • Lipid composition from MR spectroscopy reflects the rate of de novo lipogenesis and provides a potential biomarker independent from histological grade and stage.

Entities:  

Keywords:  Magnetic resonance spectroscopy (MRS); Monounsaturated fatty acids (MUFA); Saturated fatty acids (SFA); Serotonin; Triglycerides

Mesh:

Substances:

Year:  2020        PMID: 33270144     DOI: 10.1007/s00330-020-07502-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  37 in total

1.  Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.

Authors:  Ja Seung Koo; Woo-Hee Jung; Haeryoung Kim
Journal:  Am J Clin Pathol       Date:  2010-05       Impact factor: 2.493

2.  Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.

Authors:  V Ozmen; H Karanlik; N Cabioglu; A Igci; M Kecer; O Asoglu; S Tuzlali; A Mudun
Journal:  Breast Cancer Res Treat       Date:  2006-01       Impact factor: 4.872

3.  Assessment of pathologic prognostic factors in breast core needle biopsies.

Authors:  S Sharifi; M K Peterson; J K Baum; S Raza; S J Schnitt
Journal:  Mod Pathol       Date:  1999-10       Impact factor: 7.842

4.  The prognostic significance of lymphovascular invasion in invasive breast carcinoma.

Authors:  Emad A Rakha; Stewart Martin; Andrew H S Lee; David Morgan; Paul D P Pharoah; Zsolt Hodi; Douglas Macmillan; Ian O Ellis
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

Review 5.  Pathological aspects of core needle biopsy for non-palpable breast lesions.

Authors:  Shin Usami; Takuya Moriya; Atsuko Kasajima; Akihiko Suzuki; Takanori Ishida; Hironobu Sasano; Noriaki Ohuchi
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

6.  20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Authors:  Hongchao Pan; Richard Gray; Jeremy Braybrooke; Christina Davies; Carolyn Taylor; Paul McGale; Richard Peto; Kathleen I Pritchard; Jonas Bergh; Mitch Dowsett; Daniel F Hayes
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

7.  Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis.

Authors:  Nicholas George Zaorsky; Ninad Patil; Gary Mitchel Freedman; Madalina Tuluc
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

Review 8.  Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting.

Authors:  Sunati Sahoo; Susan C Lester
Journal:  Arch Pathol Lab Med       Date:  2009-04       Impact factor: 5.534

9.  Lymphangiogenesis and cancer.

Authors:  Ailsa Christiansen; Michael Detmar
Journal:  Genes Cancer       Date:  2011-12

10.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Authors:  Jack Cuzick; Ivana Sestak; Michael Baum; Aman Buzdar; Anthony Howell; Mitch Dowsett; John F Forbes
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

View more
  2 in total

1.  Peri-tumoural spatial distribution of lipid composition and tubule formation in breast cancer.

Authors:  Kwok-Shing Chan; Sai Man Cheung; Nicholas Senn; Ehab Husain; Yazan Masannat; Steven Heys; Jiabao He
Journal:  BMC Cancer       Date:  2022-03-17       Impact factor: 4.430

2.  Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.

Authors:  Shengnan Wang; Lingyu Ma; Ziyuan Wang; Huiwen He; Huilin Chen; Zhaojun Duan; Yuyang Li; Qin Si; Tsung-Hsien Chuang; Chong Chen; Yunping Luo
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.